<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01556399</url>
  </required_header>
  <id_info>
    <org_study_id>LST-UGIM</org_study_id>
    <nct_id>NCT01556399</nct_id>
  </id_info>
  <brief_title>Endoscopic Characteristics of Duodenal and Ampullary Lesions</brief_title>
  <acronym>DUO/AMP-LST</acronym>
  <official_title>A Correlation of the Endoscopic Characteristics of Duodenal and Ampullary Laterally Spreading Tumours With Their Somatic or Germline Mutations.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Professor Michael Bourke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Western Sydney Local Health District</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to investigate whether polyps that look different at endoscopy, have formed&#xD;
      via different mutations and have different risks of turning into cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laterally spreading tumours (LSTs), are polyps that have a lateral extension along the&#xD;
      duodenal wall with minimal vertical growth. It has become evident over the last few years&#xD;
      that rather than being a single entity requiring an accumulation of mutations, Duodenal and&#xD;
      ampullary cancer is in fact a heterogenous disease forming via multiple distinct genetic&#xD;
      pathways. It is therefore hypothesised that different polyp types have different genetic&#xD;
      abnormalities, and potentially form via distinct genetic pathways, although this theory has&#xD;
      not been widely examined.&#xD;
&#xD;
      This knowledge would be important in furthering our understanding of the development of&#xD;
      cancer. There is accumulating evidence that genetic abnormalities may be a better predictor&#xD;
      of cancer behaviour than histological grade. Additionally, guidelines for endoscopy&#xD;
      surveillance are currently a one size fits all approach that do not reflect the genetic&#xD;
      heterogeneity of the disease and the knowledge that only 5% of polyps progress to cancer.&#xD;
      Genetic studies may assess future cancer risk to a person in polyps once removed and plan&#xD;
      surveillance endoscopy frequency.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Significant differences in molecular abnormalities.</measure>
    <time_frame>Specimens will be stored and used for up to 15 years</time_frame>
    <description>The aim of this project is to look for statistically significant differences in molecular abnormalities from the three known genetic pathways, between the two different morphological types, granular and non-granular, to potentially demonstrate that these different polyps form via different genetic pathways.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Duodenal Diseases</condition>
  <arm_group>
    <arm_group_label>Duodenal adenomas</arm_group_label>
    <description>Patients who consent to participate in this study will have a small sample of their adenoma and normal tissue sent for molecular testing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Tissue Sampling</intervention_name>
    <description>A small sample of the duodenal adenoma will be obtained for molecular testing. The remaining adenoma will be sent for regular histological testing.</description>
    <arm_group_label>Duodenal adenomas</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Adenoma tissue sample and control &quot;regular&quot; tissue sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Duodenal and/or ampullary adenomas or cancers.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Intention to perform Endoscopic Mucosal Resection&#xD;
&#xD;
          -  Adenoma equal to or greater than 20mm&#xD;
&#xD;
          -  over 18 years of age&#xD;
&#xD;
          -  Able to give informed consent to involvement in trial&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Lactation: currently breastfeeding&#xD;
&#xD;
          -  Taken clopidogrel within 7 days&#xD;
&#xD;
          -  Taken warfarin within 5 days&#xD;
&#xD;
          -  Had full therapeutic dose unfractionated heparin within 6 hours&#xD;
&#xD;
          -  Had full therapeutic dose low molecular weight heparin (LMWH) within 12 hours&#xD;
&#xD;
          -  Known clotting disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Bourke, MBBS, FRACP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Western Sydney Local Health District</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Bourke, MBBS, FRACP</last_name>
    <phone>0409042019</phone>
    <email>kathleen.goodrick@health.nsw.gov.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Iddo Bar-Yishay, MD</last_name>
    <phone>89905555</phone>
    <email>iddo.baryishay@health.nsw.gov.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Bourke, MBBS, FRACP</last_name>
      <phone>0409042019</phone>
      <email>kathleen.goodrick@health.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Iddo Bar-Yishay, MD</last_name>
      <phone>89905555</phone>
      <email>iddo.baryishay@health.nsw.gov.au</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 15, 2012</study_first_submitted>
  <study_first_submitted_qc>March 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2012</study_first_posted>
  <last_update_submitted>March 21, 2021</last_update_submitted>
  <last_update_submitted_qc>March 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Western Sydney Local Health District</investigator_affiliation>
    <investigator_full_name>Professor Michael Bourke</investigator_full_name>
    <investigator_title>Director of Gastrointestinal Endoscopy</investigator_title>
  </responsible_party>
  <keyword>Duodenal adenoma</keyword>
  <keyword>Ampullary adenoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Duodenal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

